Racial Disparities in Resection of Early Stage Non-Small Cell Lung Cancer: Variability Among Surgeons.


Journal

Medical care
ISSN: 1537-1948
Titre abrégé: Med Care
Pays: United States
ID NLM: 0230027

Informations de publication

Date de publication:
04 2020
Historique:
pubmed: 3 1 2020
medline: 6 5 2020
entrez: 3 1 2020
Statut: ppublish

Résumé

Racial disparities in resection of non-small cell lung cancer (NSCLC) are well documented. Patient-level and system-level factors only partially explain these findings. Although physician-related factors have been suggested as mediators, empirical evidence for their contribution is limited. To determine if racial disparities in receipt of thoracic surgery persisted after patients had a surgical consultation and whether there was a physician contribution to disparities in care. The authors identified 19,624 patients with stage I-II NSCLC above 65 years of age from the Surveillance-Epidemiology and End-Results-Medicare database. They studied black and white patients evaluated by a surgeon within 6 months of diagnosis. They assessed for racial differences in resection rates among surgeons using hierarchical linear modeling. Our main outcome was receipt of NSCLC resection. A random intercept was included to test for variability in resection rates across surgeons. Interaction between patient race and the random surgeon intercept was used to evaluate for heterogeneity between surgeons in resection rates for black versus white patients. After surgical consultation, black patients were less likely to undergo resection (adjusted odds ratio, 0.57; 95% confidence interval, 0.47-0.69). Resection rates varied significantly between surgeons (P<0.001). A significant interaction between the surgeon intercept and race (P<0.05) showed variability beyond chance across surgeons in resection rates of black versus white patients. When the model included thoracic surgery specifalization the physician contribution to disparities in care was decreased. Racial disparities in resection of NSCLC exist even among patients who had access to a surgeon. Heterogeneity between surgeons in resection rates between black and white patients suggests a physician's contribution to observed racial disparities. Specialization in thoracic surgery attenuated this contribution.

Sections du résumé

BACKGROUND
Racial disparities in resection of non-small cell lung cancer (NSCLC) are well documented. Patient-level and system-level factors only partially explain these findings. Although physician-related factors have been suggested as mediators, empirical evidence for their contribution is limited.
OBJECTIVE
To determine if racial disparities in receipt of thoracic surgery persisted after patients had a surgical consultation and whether there was a physician contribution to disparities in care.
METHODS
The authors identified 19,624 patients with stage I-II NSCLC above 65 years of age from the Surveillance-Epidemiology and End-Results-Medicare database. They studied black and white patients evaluated by a surgeon within 6 months of diagnosis. They assessed for racial differences in resection rates among surgeons using hierarchical linear modeling. Our main outcome was receipt of NSCLC resection. A random intercept was included to test for variability in resection rates across surgeons. Interaction between patient race and the random surgeon intercept was used to evaluate for heterogeneity between surgeons in resection rates for black versus white patients.
RESULTS
After surgical consultation, black patients were less likely to undergo resection (adjusted odds ratio, 0.57; 95% confidence interval, 0.47-0.69). Resection rates varied significantly between surgeons (P<0.001). A significant interaction between the surgeon intercept and race (P<0.05) showed variability beyond chance across surgeons in resection rates of black versus white patients. When the model included thoracic surgery specifalization the physician contribution to disparities in care was decreased.
CONCLUSIONS
Racial disparities in resection of NSCLC exist even among patients who had access to a surgeon. Heterogeneity between surgeons in resection rates between black and white patients suggests a physician's contribution to observed racial disparities. Specialization in thoracic surgery attenuated this contribution.

Identifiants

pubmed: 31895307
doi: 10.1097/MLR.0000000000001280
pii: 00005650-202004000-00014
doi:

Types de publication

Journal Article Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

392-398

Subventions

Organisme : AHRQ HHS
ID : R01 HS019670
Pays : United States

Références

American Cancer Society. Cancer facts and figures 2014. Am Cancer Soc. 2014. Available at: https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-2014.html.
Bach PB, Cramer LD, Warren JL, et al. Racial differences in the treatment of early-stage lung cancer. N Engl J Med. 1999;341:1198–1205.
Aizer AA, Wilhite TJ, Chen MH, et al. Lack of reduction in racial disparities in cancer-specific mortality over a 20-year period. Cancer. 2014;120:1532–1539.
Forrest LF, Adams J, Wareham H, et al. Socioeconomic inequalities in lung cancer treatment: systematic review and meta-analysis. PLoS Med. 2013;10:e1001376.
Dalwadi SM, Lewis GD, Bernicker EH, et al. Disparities in the treatment and outcome of stage I non-small-cell lung cancer in the 21st century. Clin Lung Cancer. 2019;20:194–200.
Esnaola NF, Gebregziabher M, Knott K, et al. Underuse of surgical resection for localized, non-small cell lung cancer among whites and African Americans in South Carolina. Ann Thorac Surg. 2008;86:220–226.
Smith TJ, Penberthy L, Desch CE, et al. Differences in initial treatment patterns and outcomes of lung cancer in the elderly. Lung Cancer. 1995;13:235–252.
Lathan CS, Neville BA, Earle CC. The effect of race on invasive staging and surgery in non-small-cell lung cancer. J Clin Oncol. 2006;24:413–418.
Albain KS, Unger JM, Crowley JJ, et al. Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group. J Natl Cancer Inst. 2009;101:984–992.
Simpson DR, Martinez ME, Gupta S, et al. Racial disparity in consultation, treatment, and the impact on survival in metastatic colorectal cancer. J Natl Cancer Inst. 2013;105:1814–1820.
Sun M, Karakiewicz PI, Sammon JD, et al. Disparities in selective referral for cancer surgeries: implications for the current healthcare delivery system. BMJ Open. 2014;4:e003921.
van Ryn M. Research on the provider contribution to race/ethnicity disparities in medical care. Med Care. 2002;40(suppl 1):I140–I151.
van Ryn M, Fu SS. Paved with good intentions: do public health and human service providers contribute to racial/ethnic disparities in health? Am J Public Health. 2003;93:248–255.
Institute of Medicine, Board on Health Sciences Policy, Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care. Assessing potential sources of racial and ethnic disparities in care: the clinical encounter. In: Brian D, Smedley AYS, Alan RN. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Washington, DC: National Academy Press; 2003:160–179.
Cykert S, Dilworth-Anderson P, Monroe MH, et al. Factors associated with decisions to undergo surgery among patients with newly diagnosed early-stage lung cancer. JAMA. 2010;303:2368–2376.
Hamann HA, Lee JW, Schiller JH, et al. Clinician perceptions of care difficulty, quality of life, and symptom reports for lung cancer patients: an analysis from the Symptom Outcomes and Practice patterns (SOAPP) study. J Thorac Oncol. 2013;8:1474–1483.
Lin JJ, Mhango G, Wall MM, et al. Cultural factors associated with racial disparities in lung cancer care. Ann Am Thorac Soc. 2014;11:489–495.
Margolis ML, Christie JD, Silvestri GA, et al. Racial differences pertaining to a belief about lung cancer surgery: results of a multicenter survey. Ann Intern Med. 2003;139:558–563.
National Cancer Institute. Surveillance Epidemiology and End Results Database. 2013. Available at: http://seer.cancer.gov/. Accessed November 15, 2016.
Baldwin LM, Adamache W, Klabunde CN, et al. Linking physician characteristics and medicare claims data: issues in data availability, quality, and measurement. Med Care. 2002;40(suppl 8):IV):82–95.
Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613–619.
Klabunde CN, Legler JM, Warren JL, et al. A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients. Ann Epidemiol. 2007;17:584–590.
World Health Organization. International Classification of Diseases for Oncology, Third Edition. 2000.
Detterbeck FC, Boffa DJ, Tanoue LT. The new lung cancer staging system. Chest. 2009;136:260–271.
Cooper GS, Virnig B, Klabunde CN, et al. Use of SEER-Medicare data for measuring cancer surgery. Med Care. 2002;40(suppl):IV-43–48.
Schrag D, Earle C, Xu F, et al. Associations between hospital and surgeon procedure volumes and patient outcomes after ovarian cancer resection. J Natl Cancer Inst. 2006;98:163–171.
Samuel CA, Landrum MB, McNeil BJ, et al. Racial disparities in cancer care in the Veterans Affairs health care system and the role of site of care. Am J Public Health. 2014;104(suppl 4):S562–S571.
Murphy MM, Simons JP, Ng SC, et al. Racial differences in cancer specialist consultation, treatment, and outcomes for locoregional pancreatic adenocarcinoma. Ann Surg Oncol. 2009;16:2968–2977.
Baquet CR, Mishra SI, Commiskey P, et al. Breast cancer epidemiology in blacks and whites: disparities in incidence, mortality, survival rates and histology. J Natl Med Assoc. 2008;100:480–488.
Institute of Medicine Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care. Assessing Potential Sources of Racial and Ethnic Disparities in Care: Patient- and System-Level Factor. In: Smedley BD, Stith AY, Nelson AR. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Washington, DC: National Academies Press; 2003.
Silvestri GA, Gonzalez AV, Jantz MA, et al. Methods for staging non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143(suppl 5):e211S–e2250.
Nelson A. Unequal treatment: confronting racial and ethnic disparities in health care. J Natl Med Assoc. 2002;94:666–668.
Dovidio J. Stereotyping The MIT Encyclopedia of the Cognitive Sciences. Cambridge, MA: MIT Press; 1999.
Powe BD, Daniels EC, Finnie R. Comparing perceptions of cancer fatalism among African American patients and their providers. J Am Acad Nurse Pract. 2005;17:318–324.
Bergamo C, Lin JJ, Smith C, et al. Evaluating beliefs associated with late-stage lung cancer presentation in minorities. J Thorac Oncol. 2013;8:12–18.
McGuire FR, Cykert S, Dalton F, et al. Physicians attitudes about recommending surgery for early stage lung cancer and possible reasons for racial disparities. J Health Dispar Res Pract. 2014;7:50–80.
Stinchcombe TE, Detterbeck FC, Lin L, et al. Beliefs among physicians in the diagnostic and therapeutic approach to non-small cell lung cancer. J Thorac Oncol. 2007;2:819–826.
Tieu B, Schipper P. Specialty matters in the treatment of lung cancer. Semin Thorac Cardiovasc Surg. 2012;24:99–105.

Auteurs

Nicole Ezer (N)

Department of Medicine, Respiratory Division, Respiratory Epidemiology and Clinical Research Unit, McGill University, Montreal, QC, Canada.
Division of General Internal Medicine, Critical Care, and Sleep Medicine.

Grace Mhango (G)

Division of General Internal Medicine, Critical Care, and Sleep Medicine.

Emilia Bagiella (E)

Department of Health Policy and Evidence.

Emily Goodman (E)

Division of General Internal Medicine, Critical Care, and Sleep Medicine.

Raja Flores (R)

Department of Thoracic Surgery.

Juan P Wisnivesky (JP)

Division of General Internal Medicine, Critical Care, and Sleep Medicine.
Division of Pulmonary, Critical Care, and Sleep Medicine, Icahn School of Medicine at Mount Sinai.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH